$NBIX News Article - Neurocrine Biosciences to Present Data on INGREZZA (valbenazine) for Tardive Dyskinesia; Opicapone and VY-AADC for Parkinson's Disease, at the 2019 International Congress of Parkinson's Disease and Movement Disorders
https://marketwirenews.com/news-releases/neur...98895.html